5-Fluorouracil (FUra) and Folinic Acid (FA) Therapy in Patients with Colorectal Cancer

  • Charles Erlichman
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 131)


Colorectal cancer is the third most common cancer in North America today (1). Whereas surgery is the mainstay of primary therapy for this disease, it cures on average only 50% of all patients who develop this disease(2). The impact of surgery is greatest at the early stages of this cancer. When the tumour has penetrated to serosa or metastasized to local or distant sites the probability of cure with surgery alone is decreased markedly. In attempts to improve the prognosis for patients in this latter category, new therapies are constantly tested in the metastatic setting(3) and some are investigated in the adjuvant setting(4). We have performed a randomized trial comparing FUra to FUra and FA in patients with previously untreated metastatic colorectal cancer(5). I will describe this study and an ongoing trial of this combination in the adjuvant treatment of patients who have undergone curative resection of the colon.


Colorectal Cancer Oral Mucositis Adjuvant Setting FOLINIC Acid Muscularis Propria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Silverberg, E., Lubera, J.A., 1968, Cancer Statistics 1988, Ca- A Cancer Journal for Clinicians, 38: 5.Google Scholar
  2. 2.
    Surgarbaker, P., Gunderson, L.L., Wittes, R.E., 1985, Colorectal Cancer, in: Cancer Principles and Practices of Oncology, DeVita, V.T., Helleman, S., Rosenberg, S.A. ed. Lippincott Co., Toronto, 795–884.Google Scholar
  3. 3.
    Buroker, T.R., Moertel, C.G., Fleming, T.R. et al, 1985, A Controlled Evaluation of Recent Approaches to Biochemical Modulation or Enhancement of 5-fluorouracil therapy in Colorectal Carcinoma, J. Clin. Oncol. 3: 1624.PubMedGoogle Scholar
  4. 4.
    Wolmark, N., Fisher, B., Rockette, H. et al, 1988, Post-operative adjuvant chemotherapy or BCG for colon cancer: results of NSABP protocol C-01, J. Natl. Cancer Inst., 80: 30.PubMedCrossRefGoogle Scholar
  5. 5.
    Erlichman, C., Fine, S., Wong, A., Elhakim, T., 1988, A Randomized Trial of Fluorouracil and Folinic Acid in Patients with Metastatic Colorectal Cancer, J. Clin. Oncol., 6: 469.PubMedGoogle Scholar
  6. 6.
    Kroener, J.F., Saleh, F., Howell, S.B., 1982, 5-FU and Allopurinol: Toxicity Modulation and Phase II Results in Colon Cancer, Cancer Treat. Rep., 66: 1133.PubMedGoogle Scholar
  7. 7.
    Clark, P.I., Slevin, M.L., 1985, Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity, Europ. J. Surg. Oncol., 11: 267.Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Charles Erlichman
    • 1
    • 2
  1. 1.Department of MedicinePrincess Margaret HospitalAustralia
  2. 2.NCI of Canada Colorectal SubcommitteeUniversity of TorontoCanada

Personalised recommendations